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Borrelia burgdorferi sensu lato is a tick-borne pathogen that causes Lyme disease. The
characterization of membrane proteins from this and other pathogens may yield a better
understanding of the mechanisms of infection and information useful for vaccine design.
Characterization of the highly hydrophobic Borrelia outer membrane component P13 from a
mutant (OspA OspB OspC and OspD) strain was undertaken by use of a combination of
mass spectrometric methods. In a previous investigation, an electrospray ionization (ESI) mass
spectrum of the intact protein provided an average molecular weight that was 20 Da lower
than the predicted molecular weight. The mass deviation could be explained by a modification
of the N-terminus of the protein such as pyroglutamylation (17 Da) in combination with the
experimental error of measurement, however more information was required. New structural
information for this membrane protein was provided by peptide mapping with matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry (MALDI TOF MS) and sequenc-
ing with ESI-quadrupole-TOF tandem MS. ESI Fourier transform ion cyclotron resonance
(FT-ICR) MS at 9.4 tesla revealed that the Borrelia membrane protein is not only pyroglutamy-
lated, but also contains an amino acid substitution near the N-terminus. (J Am Soc Mass
Spectrom 2002, 13, 295–299) © 2002 American Society for Mass Spectrometry
Borrelia burgdorferi is a tick-borne pathogen thatcauses Lyme disease. The infection results in awide range of clinical manifestations that may
affect the skin, joints, heart, and nervous system [1].
Several investigations indicate that the borrelial cell
envelope differs substantially from that of other Gram-
negative bacteria [2–4]. B. burgdorferi cells contain an
extraordinary abundance of lipoproteins, but the den-
sity of transmembrane spanning proteins in the outer
membrane is low compared to other gram-negative
bacteria [5]. The characterization of membrane proteins
from this and other pathogens may yield a better
understanding of the mechanisms of infection and
information useful for vaccine design.
Mass spectrometry is a valuable technique for pro-
tein structural analysis. Peptide mapping [6–9] by
MALDI-TOF MS can rapidly identify known proteins
and their post-translational modifications. Peptide
mapping may provide sufficient data alone, but tandem
mass spectrometry can be employed to obtain de novo
amino acid sequences and confirm the nature of peptide
post-translational modifications [10, 11]. High resolu-
tion, high mass accuracy techniques can improve the
rate of success of identification of proteins for which the
gene sequence is known, as well as post-translational
modifications. The highest performance mass analyzer
is the FT-ICR mass spectrometer [12]. Recent develop-
ments have demonstrated that analyses of biological
materials can be performed at a high level of sensitivity,
when microelectrospray [13] is the ionization mode
[14–16].
Characterization of the highly hydrophobic Borrelia
outer membrane component P13 from the OspA
OspB OspC and OspD mutant strain [17] was
undertaken through a combination of mass spectromet-
ric methods. In an earlier investigation [18], an electro-
spray ionization (ESI) mass spectrum of the intact
protein provided an average molecular weight that was
20 Da lower than the predicted molecular weight. The
mass deviation could be explained by a modification of
the N-terminus of the protein such as pyroglutamyla-
tion (17 Da) in combination with the experimental
error of measurement; however more information was
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required. Edman sequencing of the N-terminus failed,
increasing the suspicion that the terminus was blocked.
Because the P13 protein is immunogenic and a putative
vaccine component, extensive characterization was de-
sirable.
Methods
Sample Preparation
Approximately 0.1 mg of P13 protein purified as previ-
ously described [18] was dissolved in SDS-PAGE sam-
ple buffer and electrophoresed in a 15% SDS-PAGE gel
(Novex). The gel was stained with GelCode Blue Stain
Reagent (Pierce, USA). The protein band was excised
and destained by adding 85 L 25 mM NH4HCO3 in 50%
CH3CN and vortexing for 30 min, after which the super-
natant was removed. This procedure was repeated twice.
Gel pieces were dried for 40 min in a vacuum centrifuge
(SpeedVac, Savant Inc. USA). Fifteen L modified porcine
trypsin (sequencing grade, Promega) in 25 mM
NH4HCO3, pH 8, was added. The tubes were incubated
for 16 h at 37 °C. Peptides were extracted from the gel by
adding 15 L 5% CF3COOH in 75% CH3CN to the tube
and vortexing for 30 min. Extracted peptides were subse-
quently analyzed by mass spectrometry.
MALDI-TOF-MS
Samples were analyzed with a Micromass TofSpecE
MALDI-TOF mass spectrometer (Micromass, Manches-
ter, UK) equipped with a pulsed 337 nm nitrogen laser,
a delayed extraction ion source and a reflectron. One-
half L sample was mixed with 0.5 L matrix solution
(CHCA 10 mg/mL in acetonitrile:H2O, 1:1) directly on
the cylindrically machined MALDI probe and allowed
to dry at ambient conditions. Peptide spectra were
acquired in reflectron mode at an accelerating voltage of
20 kV; 200 laser shots were summed. External calibra-
tion with angiotensin II and ACTH (18–39) was em-
ployed. This procedure typically results in mass accu-
racies of 200 ppm or better. The mass accuracy can be
improved to better than 100 ppm if a second calibration
with an autodigestion product of porcine trypsin
(2211.105 Da) is performed. Resulting values for mo-
noisotopic peaks were matched against the theoretical
masses from tryptic digestion of the mature P13 protein
according to the published sequence.
ESI-Quadrupole-TOF-MS(/MS)
Tryptic peptides were analyzed by nanoflow ESI-MS
and tandem MS (MS/MS) in a QTof instrument (Micro-
mass, Manchester, UK). Peptide samples were dissolved
in 3 L acetonitrile:H2O (1:1) containing 1% acetic acid
and sprayed from gold-coated glass capillaries (Micro-
mass). The collision gas was argon. Instrument calibration
was performed by use of fragment ions from Glu-fibrino-
peptide B and a fourth order polynomial fit. This proce-
dure gives mass accuracies of 100 ppm or better. Both
MALDI- and ESI-MS spectra were analyzed with the
MassLynx (Manchester, UK) software.
ESI-FTICR-MS
A homebuilt, passively shielded, 9.4 tesla FT-ICR mass
spectrometer [19] equipped with microelectrospray ion-
ization [13] was used for accurate mass determination
of the tryptic peptides. The peptides were infused at a
flow rate of 500 nL/min through an electrospray emit-
ter consisting of a 50 m i.d. fused silica capillary,
which had been mechanically ground to a uniform
thin-walled tip [20]. The electrosprayed ions were trans-
ported into the mass spectrometer through a Chait-style
atmosphere-to-vacuum interface [21] and externally ac-
cumulated [22] for 2 s in an octopole pretrap. After
accumulation, the collected ions were transferred
through multipole ion guides and captured by gated
trapping in an open [23] cylindrical cell. The ions were
subjected to chirp excitation (72 to 320 kHz at 150
Hz/s) and direct-mode broadband detection (1
Mword data points). Hanning apodization and one zero
fill was applied prior to fast Fourier transform (FFT)
followed by magnitude calculation. The experimental
event sequence was controlled by a modular ICR data
acquisition system (MIDAS) [24]. Internal frequency-to-
m/z calibration [25] was performed with respect to two
components (m/z 922.00979 and 1521.97146) of an added
#G2421A electrospray tuning mix from Agilent Tech-
nologies (Wilmington, DE). The presented spectrum
represents a sum of 30 time-domain transients.
Results and Discussion
Peptide Mass Mapping of the P13 Protein by
MALDI-TOF-MS
All tryptic peptides except one, corresponding to the
highly hydrophobic amino acid sequence 26–76, were
detected and assigned (Table 1). The two autolytic
peptides from trypsin were not visible in the MALDI
spectrum, therefore the error of measurement was ap-
proximately 150 ppm. The peptide observed at m/z
1711.9 corresponds to the unmodified N-terminal pep-
tide (QANDSKNGAFGMSAGEK) of the published
amino acid sequence, within the error of the MALDI
measurement. This result is at odds with previous data,
which suggested that the N-terminus is modified, how-
ever the peptide at m/z 1696.0 deviates by 1 Da from
the pyroglutamylated form of the N-terminal peptide.
MS/MS of a Doubly Protonated Peptide at m/z
848.4
Tandem mass spectrometry was performed on a doubly
protonated precursor ion observed at m/z 848.4 with the
QTof instrument, corresponding to the singly proton-
ated peptide at m/z 1696.0 in the MALDI-TOF spectrum
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with a mass deviation of 1 Da compared to the
pyroglutamylated form of the published N-terminal
sequence. The MS/MS spectrum (Figure 1) gave the
amino acid sequence (pQANDSKDGAFGMSAGEK),
providing evidence that the peptide is pyroglutamy-
lated and contains one amino acid substitution. The
substitution of D for N leads to an increase in mass of 1
Da. No satisfactory MS/MS data was obtained for the
peptide corresponding to protonated mass 1711.9.
ESI-FTICR-MS of the Tryptic Digest
After finding the amino acid substitution N7D, we
realized that the singly protonated peptide at m/z
1711.9, as measured by MALDI-TOF- and ESI-qTOF-
MS, could match two possible forms of the protein
N-terminus within the range of experimental error of
these instruments: the unmodified peptide QANDSKN
GAFGMSAGEK (monoisotopic protonated mass
1711.7701), or the pyroglutamylated and methionine
oxidized form pQANDSKDGAFGM*SAGEK (monoiso-
topic protonated mass 1711.7226), which differ by the
elemental composition N2H4 versus O2. Therefore, the
digest was analyzed in the high performance 9.4 tesla
FTICR instrument at the National High Magnetic Field
Laboratory (NHMFL) in Tallahassee, Florida, fitted
with a microelectrospray source. The spectrum is
shown in Figure 2 and the results summarized in Table
2. The mass accuracy of the FT-ICR instrument unam-
biguously identified the m/z 1711.9 peptide as the
methionine oxidized form of the pyroglutamylated N-
terminal peptide with the sequence pQANDSKDGAF
GMSAGEK.
Conclusion
The results of this investigation serve to illustrate the
relative strengths and limitations of three of the mass
Table 1. Summary of ions observed in MALDI-TOF-MS analysis of tryptic digest P13 protein from Borrelia burgderferi
Assignmenta M  H (calc.) M  H (obs.) Dev. (ppm)
(18–25) 952.54 952.66 126
(85–93) 1094.54 1093.69 137
(84–937) 1222.64 1222.80 131
(94–107) 1404.77 1404.99 157
(94–107) Met–ox 1420.77 1420.97 141
(94–107) 2Met–ox 1436.76 1436.97 146
??(1–17)pGlu 1694.74 1695.99 b
(1–17) 1711.77 1711.88 64
108–123 1899.00 1899.26 137
(77–93) 1921.03 1921.20 88
(108–124) 2027.10 2027.35 123
aAssignments were made by comparing observed peptide masses with a theoretical digest of the mature P13 protein according to the published
sequence.
bOut of mass accuracy range.
Figure 1. MS/MS spectrum of a doubly protonated peptide of
m/z 848.4 in an ESI-qTOF mass spectrometer. The spectrum
revealed pyroglutamylation of the N-terminus and the substitu-
tion of D for N at the seventh position.
Figure 2. 9.4 tesla FTICR mass spectrum obtained by microelec-
trospray ionization of an unfractionated tryptic digest of the P13
membrane protein of a mutant strain of Borrelia burgdorferi. The
achieved resolving power was approximately 35,000 and mass
accuracy was better than 2 ppm. Peptide assignments are given in
brackets.
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spectrometric techniques that are most widely em-
ployed in protein characterization. Peptide mapping by
MALDI-TOF-MS is a rapid and sensitive technique, but
incorrect assignments of peptide identities, based on
molecular mass alone, may result if mass accuracy is
low. Here, the relatively low mass accuracy (of the
order of 150 ppm) of the MALDI-TOF data resulted in
an incorrect assignment of the peptide of m/z 1711.9 to
the unmodified N-terminal peptide of the published
(and for this strain, incorrect) P13 protein sequence. The
peptide of m/z 1696.0 revealed an incongruity in the
actual protein and its published sequence, and stimu-
lated further investigation.
Tandem mass spectrometry is an excellent tool to
obtain sequence confirmation for tryptic peptides,
often resulting in spectra from which the amino acid
sequence can be read directly. An unambiguous
MS/MS spectrum from a doubly protonated peptide
of m/z 848.4, corresponding to the measured singly
protonated peptide of m/z 1696.0 by MALDI-TOF-MS,
demonstrated the cyclization of the N-terminal glu-
tamine residue and the substitution of D for N in the
seventh position. However, no conclusive MS/MS
spectrum was obtained for the peptide corresponding
to the ion of m/z 1711.9 observed by MALDI-TOF-MS.
The molecular mass of this species could be assigned
to two possible sequences within the mass accuracy
limits of the MALDI-TOF and ESI-qTOF analyses
(Table 2). However, the high mass accuracy (2 ppm)
data provided by the 9.4 tesla ESI-FTICR instrument
at the NHMFL confirmed that the Borrelia membrane
protein was pyroglutamylated and contained a sub-
stitution of D for N at the seventh position, the result
of a point mutation of adenine to guanine in the
genetic material of this strain. The new structural
information for this membrane protein was thus
provided by several mass spectrometric techniques.
Because the N-terminus may be surface-exposed and
accessible to the cellular and humoral immune sys-
tems, the information is highly relevant to vaccine
design.
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